Clinical Trial Detail

NCT ID NCT03114228
Title An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

acute myeloid leukemia

Therapies

Midostaurin

Age Groups: senior adult

Additional content available in CKB BOOST